Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women (Q80535508)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 June 2007
edit
Language Label Description Also known as
English
Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women
scientific article published on 26 June 2007

    Statements

    Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit